Ligandability assessment of the LAG-3 D1 domain enables discovery of a small-molecule inhibitor
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
vaccines and immunoinformatics approaches
Immunotherapy and Immune Responses
Publication details
- Journal / source
- Journal of Molecular Graphics and Modelling
- Publisher
- Elsevier BV
- Volume
- 146
- Pages
- 109435–109435
- Publication date
- 9 May 2026
- Language
- EN